These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16615495)

  • 1. [Oka varicella vaccine as a novel vaccine vector].
    Shiraki K; Suzuki M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():340-4. PubMed ID: 16615495
    [No Abstract]   [Full Text] [Related]  

  • 2. Varicella vaccine: genesis, efficacy, and attenuation.
    Arvin AM
    Virology; 2001 Jun; 284(2):153-8. PubMed ID: 11384215
    [No Abstract]   [Full Text] [Related]  

  • 3. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
    Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
    J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine].
    Shiraki K; Takahara T
    Nihon Rinsho; 1993 Jan; 51(1):241-7. PubMed ID: 8381884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of humoral and cell-mediated immunity to hepatitis B surface antigen by a novel adjuvant activity of Oka varicella vaccine.
    Phumiamorn S; Sato H; Kamiyama T; Kurokawa M; Shiraki K
    J Gen Virol; 2003 Feb; 84(Pt 2):287-291. PubMed ID: 12560559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable and consistent genetic profile of Oka varicella vaccine virus is not linked with appearance of infrequent breakthrough cases postvaccination.
    Vassilev V
    J Clin Microbiol; 2005 Oct; 43(10):5415-6; author reply 5416-7. PubMed ID: 16208038
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
    Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
    J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen.
    Kamiyama T; Sato H; Takahara T; Kageyama S; Shiraki K
    J Infect Dis; 2000 Mar; 181(3):1158-61. PubMed ID: 10720546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
    Breuer J; Schmid DS
    J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oka varicella vaccines are more equal than different.
    Rentier B; Gershon AA
    Vaccine; 2004 Sep; 22(25-26):3225-6; author reply 3227. PubMed ID: 15308340
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical overview of varicella vaccine: development and early studies.
    Takahashi M
    Pediatrics; 1986 Oct; 78(4 Pt 2):736-41. PubMed ID: 3020493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
    Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
    Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.
    Grose C
    J Clin Virol; 2005 Jun; 33(2):89-95; discussion 96-8. PubMed ID: 15911422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The varicella vaccine.
    Arvin AM
    Curr Clin Top Infect Dis; 1997; 17():110-46. PubMed ID: 9189664
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.